At a glance
ClinicalIndex Comparison RecordN/ACompleted· 49 enrolled
Drug / intervention
PAAG-OAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Open-label Clinical Investigation of Intra-articular Polyacrylamide Hydrogel Injection in Subjects With Knee Osteoarthritis
In Brief
A clinical study evaluating PAAG-OA for Osteoarthritis, Knee. Completed, enrolled 49 participants across 3 sites.
Detailed Summary
This is a multi-centre, prospective, open-label, uncontrolled, clinical investigation followed by an open-label extension clinical investigation to evaluate PAAG-OA in patients with knee osteoarthritis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Knee
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartAug 2019
First PostedNov 2019
Primary CompletionFeb 2020
Study CompletionSep 2024
TodayJul 2026
First PostedNov 27, 2019
Enrollment StartAug 21, 2019
Primary CompletionFeb 7, 2020
Study CompletionSep 19, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.6 years ago
Interventions
PAAG-OAdevice
Intra-articular injection with PAAG-OA (polyacrylamide hydrogel)